Press Releases

30/03/2005
Coridon Chairman Professor Ian Frazer receives the prestigious Curtin Medal from Australian National University for his outstanding contribution to medical science. To see an article from the Canberra Times about this click here.

February 2005
Coridon receives a research and development START grant of $1.48 million from AusIndustry, the Australian Government’s agency for delivering products, services and information that support industry, research and innovation. To see click here.

July 2004
Ian Frazer honoured by major Fellowship
Professor Ian Frazer, a University of Queensland researcher based at the Princess Alexandra Hospital in Brisbane has become one of the youngest, and only the 22nd Queenslander to be inducted into the prestigious Australian Academy of Sciences.

Ian received Fellow status recognition of work that led to the development of a vaccine to prevent cervical cancer, but alos for the significant contribution that he has made to scientific research over his illustrious career.
“Being made an Australian Academy of Sciences fellow was an unexpected honour because I never thought of myself in that league,” he said. Also, I saw becoming a fellow of the AAS as recognition received towards the end of a career, whereas I see myself working in research for a lot longer yet.”
As Director of the Centre for Immunology and Cancer Research., Ian sees this fellowship as an opportunity to extend his role as a lobbyist for bioscience.
“Biomedical research is a good investment because it can provide better health outcomes for the local, national and international community, and can result in marketable products that will benefit the local economy”, he said.
Ian describes the AAS as an independent group of scientists who carry a lot of weight as a source of expert opinion in science, and who aim to keep science at the forefront of peoples’ minds.
“Only 16 scientists are inducted into the Australian Academy of Sciences each year,” he said.
“I have a strong desire to see more of these fellows come from a bioscience background, to use the opportunities presented by the AAS to influence government policy and investment, and to enhance cooperation with other affiliated organizations.”
Health matters 9, 6th July 2004.

Publications

June 1999
Papillomavirus Capsid Protein Expression Level Depends on the Match between Codon Usage and tRNA Availability

J. Zhou, W. J. Liu, S. W. Pang, X. Y. Sun, and I. H. Frazer. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J.Virol. 73 (6):4972-4982, 1999.

Download by clicking here.

August 2001
Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

W. J. Liu, K. N. Zhao, F. G. Gao, G. R. Leggatt, G. J. P. Fernando, and I. H. Frazer. Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine 20 (5-6):862-869, 2001.

Download by clicking here.

May 2002
Codon Modified Human Papillomavirus Type 16 E7 DNA Vaccine Enhances Cytotoxic T-Lymphocyte Induction and Anti-tumour Activity.

W. J. Liu, F. G. Gao, K. N. Zhao, W. M. Zhao, G. J. G. Fernando, R. Thomas, and I. H. Frazer. Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology 301 (1):43-52, 2002.

Download by clicking here.

To view these articles you will need Adobe Acrobat Reader. If you don't have this you can download it by clicking here.